Osamu Yokosuka is an Emeritus Professor of Chiba University, Japan. He graduated from Chiba University School of Medicine in 1975 then worked as a trainee under Professor K. Okuda in Chiba University Hospital till 1978. Dr. Yokosuka was a research fellow worked under Professor S. Scherlock and Professor B. H. Billing in Royal Free Hospital, London, UK from 1978 to 1980; under Professor M. Omata in Chiba University from 1980 to 1985; and under Dr. J Summers in Fox Chase Cancer Center, PA, USA in 1984. In 1985, he received a Degree of Doctor of Medical Science, and served as an Assistant Professor in Chiba University till 1994, then as Lecturer in Medicine till 2006 when he was appointed as Director and Professor of Medicine. From 2013 to 2015, he served as the Dean of Chiba University School of Medicine.
Dr. Yokosuka was the Secretary General of APASL (2008-2014). In 2016, he was elected as the President of APASL Tokyo, the President of 52nd Annual Meeting of Japan Society of Hepatology, and the President of Funabashi Central Hospital. Dr. Yokosuka’s research mainly focuses on Hepatitis and Hepatocellular Carcinoma. So far, he has published more than 700 original papers.
Tatsuo Kanda received a medical degree in 1991 at Niigata University School of Medicine, Japan, and his PhD in 1999 at Chiba University Graduate School of Medicine, Japan. He had post-doctor training for 3 years under Prof. Ratna Ray and Prof. Ranjit Ray at Saint Louis University, St. Louis, MO, USA. In Dec. 2008, Tatsuo Kanda became a Tenure-track Associate Professor at Department of Medicine and Clinical Oncology, Chiba University, Graduate School of Medicine, Japan. In Feb. 2013, Tatsuo Kanda was nominated a permanent Associate Professor at Department of Gastroenterology and Nephrology, Chiba University, Graduate School of Medicine, Japan. In 2017, Tatsuo Kanda became an Associate Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nihon University School of Medicine. For ~25 years, he has focused his scientific interests on the topics related to liver diseases including acute liver failure, viral hepatitis and autoimmune liver diseases, and worked with Prof. Osamu Yokosuka. Tatsuo Kanda is also an expert for hepatitis A virus (HAV), HBV and HCV, and translation and replication of these viruses, and hepatocarcinogenesis. With his expertise in antiviral therapies and hepatitis virus research, Tatsuo Kanda also sees a lot of patients in clinical daily practice. Tatsuo Kanda has published more than 200 articles in peer-reviewed Journal.
Diagnosis and Management of Infections in Solid Organ Transplant Recipients
Submission Deadline: October 30, 2018 (Open) Submit Now
Maricar Malinis, MD FACP, FIDSA
About This Topic
Solid organ transplantation is an established life -saving therapy for end-organ diseases of the kidney, liver, heart, and lungs. The improved patient and graft survivals have been attributed to advancements in surgical techniques and effective immunosuppressive therapies. However, immune suppression, pre-existing co-morbidities, and potential surgical complications can result in infectious complications after organ transplantation. In this particular issue of OBM transplantation, solicited articles will focus on review of current approaches to the diagnosis and management of post-transplant infections in solid organ transplant recipients due to bacterial, viral and fungal pathogens. Each article will also address strategies of screening and prevention of post-transplant infections.
Title: Fungal Infections in Solid Organ Transplant
Title: Clinical management of bacterial and fungal infections in the early and late post-transplant
Title: New frontiers in Solid Organ Transplantation from donors with human immunodeficiency virus infection, hepatitis C virus infection, and multidrug resistant organisms
Title: Non-CMV viral infections following solid-organ transplantation – focus on HTLV-1 and human herpes virus 6,7 and 8
Title: Fungal Diagnostics in Solid Organ Transplantation
Title: Role of the Procalcitonin for predicting infection in Solid Organ Transplant Recipients: Review
Title: Current Management of CMV in Adult Liver Transplant Patients
Title: Specific Antibody Deficiency in a heart recipient with systemic aspergillosis
Title: Tuberculosis screening and treatment in Solid Organ Transplantation
Title: Challenges in Diagnosis and Management of Non-Tuberculous Mycobacterial Infections in SOT
Title: Diagnosis and Management of Flaviviruses in Solid Organ Transplantation
Title: Screening for BK nephropathy: is there any evidence?
Title: A Certain Uncertainty: acceptance of HPV vaccination in kidney transplant recipients
Title: Parvovirus Infections in Solid Organ Transplant Recipients
Title: Chagas disease, leishmaniasis and malaria in solid organ transplant recipients
Title: Beta HPV detection in Solid Organ Transplant Recipients: our case series
Title: Epidemiology, clinical features and outcome of urinary tract infections in kidney transplant patients due multidrug-resistant bacteria
Title: Evaluation of the renal graft function after HCV treatment with interferon-free directly acting antiviral: a centre experience
Title: KIDNEY FUNCTION AFTER TREATMENT OF HEPATITIS C INFECTION WITH NEW DIRECT-ACTION ANTIVIRALS IN KIDNEY TRANSPLANT PATIENTS
Title:Viral infections in Lung Transplant Recipients and Implications for Long Term Outcomes
Title: Isolated Hepatic Mucormycosis in the Early Post-Transplant Period: A Case Report and Literature Review